Ascentage Pharma Group International (AAPG) Accumulated Expenses (2023 - 2024)

Historic Accumulated Expenses for Ascentage Pharma Group International (AAPG) over the last 2 years, with Q4 2024 value amounting to $2.1 million.

  • Ascentage Pharma Group International's Accumulated Expenses rose 26386.54% to $2.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.1 million, marking a year-over-year increase of 26386.54%. This contributed to the annual value of $2.0 million for FY2024, which is 25145.04% up from last year.
  • As of Q4 2024, Ascentage Pharma Group International's Accumulated Expenses stood at $2.1 million, which was up 26386.54% from $568049.5 recorded in Q4 2023.
  • In the past 5 years, Ascentage Pharma Group International's Accumulated Expenses ranged from a high of $2.1 million in Q4 2024 and a low of $568049.5 during Q4 2023